http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Jialing Ou (검색결과 2 건)
- 무료
- 기관 내 무료
- 유료
-
Compressive strength of circular concrete filled steel tubular stubs strengthened with CFRP
Jialing Ou,Yong-Bo Shao 국제구조공학회 2021 Steel and Composite Structures, An International J Vol.39 No.2
The compressive strength of circular concrete filled steel tubular (C-CFST) stubs strengthened with carbon fiber reinforced polymer (CFRP) is studied theoretically. According to previous experimental results, the failure process and mechanism of circular CFRP-concrete filled steel tubular (C-CFRP-CFST) stubs is analyzed, and the loading process is divided into 3 stages, i.e., elastic stage, elasto-plastic stage and failure stage. Based on continuum mechanics, the theoretical model of C-CFRP-CFST stubs under axial compression is established based on the assumptions that steel tube and concrete are both in three-dimensional stress state and CFRP is in uniaxial tensile stress state. Equations for calculating the yield strength and the ultimate strength of C-CFRP-CFST stubs are deduced. Theoretical predictions from the presented equations are compared with existing experimental results. There are a total of 49 tested specimens, including 15 ones for comparison of yield strength and 44 ones for comparison of ultimate strength. It is found that the predicted results of most specimens are within an error limit of 10%. Finally, simplified equations for calculating both yield strength and ultimate strength of C-CFRP-CFST stubs are proposed.
-
Xiaoning Wu,Xiaoqian Xu,Jialing Zhou,Yameng Sun,Huiguo Ding,Wen Xie,Guofeng Chen,Anlin Ma,Hongxin Piao,Bingqiong Wang,Shuyan Chen,Tongtong Meng,Xiaojuan Ou,Hwai-I Yang,Jidong Jia,Yuanyuan Kong,Hong Yo 대한간학회 2023 Clinical and Molecular Hepatology(대한간학회지) Vol.29 No.3
Background/Aims: Existing hepatocellular carcinoma (HCC) prediction models are derived mainly from pretreatment or early on-treatment parameters. We reassessed the dynamic changes in the performance of 17 HCC models in patients with chronic hepatitis B (CHB) during long-term antiviral therapy (AVT). Methods: Among 987 CHB patients administered long-term entecavir therapy, 660 patients had 8 years of follow-up data. Model scores were calculated using on-treatment values at 2.5, 3, 3.5, 4, 4.5, and 5 years of AVT to predict threeyear HCC occurrence. Model performance was assessed with the area under the receiver operating curve (AUROC). The original model cutoffs to distinguish different levels of HCC risk were evaluated by the log-rank test. Results: The AUROCs of the 17 HCC models varied from 0.51 to 0.78 when using on-treatment scores from years 2.5 to 5. Models with a cirrhosis variable showed numerically higher AUROCs (pooled at 0.65–0.73 for treated, untreated, or mixed treatment models) than models without (treated or mixed models: 0.61–0.68; untreated models: 0.51–0.59). Stratification into low, intermediate, and high-risk levels using the original cutoff values could no longer reflect the true HCC incidence using scores after 3.5 years of AVT for models without cirrhosis and after 4 years of AVT for models with cirrhosis. Conclusions: The performance of existing HCC prediction models, especially models without the cirrhosis variable, decreased in CHB patients on long-term AVT. The optimization of existing models or the development of novel models for better HCC prediction during long-term AVT is warranted.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
